CD8+T-cells: Function and response to HIV infection

被引:97
作者
Gulzar, N [1 ]
Copeland, KFT [1 ]
机构
[1] Ottawa Hlth Res Inst, Ctr Mol Med, Ottawa, ON K1H 8L6, Canada
关键词
HIV; CD8+T-cell; CTL; chemokine; cytokine;
D O I
10.2174/1570162043485077
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD8+ T-cells are a critical component of the cellular immune response and they play an important role in the control of viral infection. During HIV infection, CD8+ T-cells are able to recognize infected cells through an MHC-I dependent process and are able to lyse cells harboring viral infection by the secretion of perforin and granzymes. These cytotoxic T-lymphocytes (CTL) can also eliminate virally infected cells through the engagement of death-inducing ligands expressed by CD8+ T-cells with death receptors on the surface of the infected cell. In addition, CD8+ CTL secrete soluble factors such as P-chemokines and the CD8+ antiviral factor (CAF) that suppress viral binding and transcription, respectively. In order for HIV to survive the pressures placed upon it by the immune system, the virus has adopted numerous strategies to evade the CD8+ T-cell response. The high mutation rate of HIV has allowed the virus to escape CD8+ T-cell recognition in addition to its ability to down-regulate surface MHC-1 expression from infected cells. Also, by altering the pattern of cytokine production and engagement of cellular receptors, HIV disrupts proper CD8+ T-cell signaling. The resultant improper T-cell receptor (TcR) stimulation creates an anergic state in these cells. By affecting the function of CD4+ T-cells and antigen presenting cells that are required for proper CD8+ T-cell maturation, HIV is able to decrease the circulating pool of effector and memory CD8+ T-cells that are able to combat viral infection. The end result is the aberration of CD8+ T-cell function.
引用
收藏
页码:23 / 37
页数:15
相关论文
共 288 条
[21]   Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodeficiency syndrome [J].
Barker, E ;
Mackewicz, CE ;
Reyes-Terán, G ;
Sato, A ;
Stranford, SA ;
Fujimura, SH ;
Christopherson, C ;
Chang, SY ;
Levy, JA .
BLOOD, 1998, 92 (09) :3105-3114
[22]   Human immunodeficiency virus type 1 Tat induces apoptosis and increases sensitivity to apoptotic signals by up-regulating FLICE/caspase-8 [J].
Bartz, SR ;
Emerman, M .
JOURNAL OF VIROLOGY, 1999, 73 (03) :1956-1963
[23]   ENHANCED ESTABLISHMENT OF A VIRUS CARRIER STATE IN ADULT CD4+ T-CELL-DEFICIENT MICE [J].
BATTEGAY, M ;
MOSKOPHIDIS, D ;
RAHEMTULLA, A ;
HENGARTNER, H ;
MAK, TW ;
ZINKERNAGEL, RM .
JOURNAL OF VIROLOGY, 1994, 68 (07) :4700-4704
[24]   Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease [J].
Berger, EA ;
Murphy, PM ;
Farber, JM .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :657-700
[25]   Analysis of total human immunodeficiency virus (HIV)-specific CD4+ and CD8+ T-cell responses:: Relationship to viral load in untreated HIV infection [J].
Betts, MR ;
Ambrozak, DR ;
Douek, DC ;
Bonhoeffer, S ;
Brenchley, JM ;
Casazza, JP ;
Koup, RA ;
Picker, LJ .
JOURNAL OF VIROLOGY, 2001, 75 (24) :11983-11991
[26]  
BHANDOOLA A, 1993, J IMMUNOL, V151, P2355
[27]   GALACTOSYL CERAMIDE OR A DERIVATIVE IS AN ESSENTIAL COMPONENT OF THE NEURAL RECEPTOR FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN GP120 [J].
BHAT, S ;
SPITALNIK, SL ;
GONZALEZSCARANO, F ;
SILBERBERG, DH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (16) :7131-7134
[28]   HIV-1 Nef downregulates MHC-I by a PACS-1-and PI3K-regulated ARF6 endocytic pathway [J].
Blagoveshchenskaya, AD ;
Thomas, L ;
Feliciangeli, SF ;
Hung, CH ;
Thomas, G .
CELL, 2002, 111 (06) :853-866
[29]   CD4+ and CD8+ T cell death during human immunodeficiency virus infection in vitro [J].
Blanco, J ;
Barretina, J ;
Cabrera, C ;
Gutiérrez, A ;
Clotet, B ;
Esté, JA .
VIROLOGY, 2001, 285 (02) :356-365
[30]   Cell killing by HIV-1 protease [J].
Blanco, R ;
Carrasco, L ;
Ventoso, I .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (02) :1086-1093